Summary & Explanation
{"type":"root","children":[{"type":"paragraph","children":[{"type":"text","value":"Anaplastic Lymphoma Kinase (ALK) was originally discovered as a NPM (Nucleophosmin)-ALK fusion protein. The ALK gene is on chromosome 2. Upon translocation between chromosome 2 and chromosome 5 t(2;5), the ALK gene fuses with the NPM gene. The chimeric product (NPM ALK) resulting from t(2;5) translocation is a protein of 80 kDa with the N terminal portion of NPM linked to the complete intracellular portion of ALK."}]},{"type":"paragraph","children":[{"type":"text","value":"This antibody recognizes a human p80 protein, identified as a hybrid of the Anaplastic Lymphoma Kinase (ALK) gene and the Nucleophosmin (NPM) gene resulting from the t(2;5)(p23;q35) translocation found in a third of Large-Cell Lymphomas. ALK-1 is detected in 60% of Anaplastic Large-Cell Lymphomas and has proven to indicate a better prognosis in the ALK-1 (+) group."}]}]}
Antibody Type
Rabbit Monoclonal
Clone
RBT-ALK1
Isotype
IgG
Localization
Cytoplasmic, Nuclear
Dilution
1:100-1:500
Species Reactivity
Human
Immunogen
Recombinant protein corresponding to the tyrosine kinase catalytic region of the human ALK protein.
